A retrospective study to assess 2-year visual prognosis of treatment-naïve, center-involving DME managed by retina specialists in Japan with use of anti-VEGF agents
Latest Information Update: 12 Mar 2021
At a glance
- Drugs Aflibercept (Primary) ; Bevacizumab (Primary) ; Corticosteroid (Primary) ; Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms STREAT-DME
- 12 Mar 2021 New trial record